Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction

Abstract Abnormalities in electroencephalographic (EEG) biomarkers occur in patients with schizophrenia and those clinically at high risk for transition to psychosis and are associated with cognitive impairment. Converging evidence suggests N-methyl-D-aspartate receptor (NMDAR) hypofunction plays a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: David D. Aguilar, Leana K. Radzik, Felipe L. Schiffino, Oluwarotimi O. Folorunso, Mark R. Zielinski, Joseph T. Coyle, Darrick T. Balu, James M. McNally
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f8ea1784276d4c4a8fbcc40d7b2e1e8c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f8ea1784276d4c4a8fbcc40d7b2e1e8c
record_format dspace
spelling oai:doaj.org-article:f8ea1784276d4c4a8fbcc40d7b2e1e8c2021-12-02T13:41:34ZAltered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction10.1038/s41598-021-88428-92045-2322https://doaj.org/article/f8ea1784276d4c4a8fbcc40d7b2e1e8c2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88428-9https://doaj.org/toc/2045-2322Abstract Abnormalities in electroencephalographic (EEG) biomarkers occur in patients with schizophrenia and those clinically at high risk for transition to psychosis and are associated with cognitive impairment. Converging evidence suggests N-methyl-D-aspartate receptor (NMDAR) hypofunction plays a central role in the pathophysiology of schizophrenia and likely contributes to biomarker impairments. Thus, characterizing these biomarkers is of significant interest for early diagnosis of schizophrenia and development of novel treatments. We utilized in vivo EEG recordings and behavioral analyses to perform a battery of electrophysiological biomarkers in an established model of chronic NMDAR hypofunction, serine racemase knockout (SRKO) mice, and their wild-type littermates. SRKO mice displayed impairments in investigation-elicited gamma power that corresponded with reduced short-term social recognition and enhanced background (pre-investigation) gamma activity. Additionally, SRKO mice exhibited sensory gating impairments in both evoked-gamma power and event-related potential amplitude. However, other biomarkers including the auditory steady-state response, sleep spindles, and state-specific power spectral density were generally neurotypical. In conclusion, SRKO mice demonstrate how chronic NMDAR hypofunction contributes to deficits in certain translationally-relevant EEG biomarkers altered in schizophrenia. Importantly, our gamma band findings suggest an aberrant signal-to-noise ratio impairing cognition that occurs with NMDAR hypofunction, potentially tied to impaired task-dependent alteration in functional connectivity.David D. AguilarLeana K. RadzikFelipe L. SchiffinoOluwarotimi O. FolorunsoMark R. ZielinskiJoseph T. CoyleDarrick T. BaluJames M. McNallyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
David D. Aguilar
Leana K. Radzik
Felipe L. Schiffino
Oluwarotimi O. Folorunso
Mark R. Zielinski
Joseph T. Coyle
Darrick T. Balu
James M. McNally
Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
description Abstract Abnormalities in electroencephalographic (EEG) biomarkers occur in patients with schizophrenia and those clinically at high risk for transition to psychosis and are associated with cognitive impairment. Converging evidence suggests N-methyl-D-aspartate receptor (NMDAR) hypofunction plays a central role in the pathophysiology of schizophrenia and likely contributes to biomarker impairments. Thus, characterizing these biomarkers is of significant interest for early diagnosis of schizophrenia and development of novel treatments. We utilized in vivo EEG recordings and behavioral analyses to perform a battery of electrophysiological biomarkers in an established model of chronic NMDAR hypofunction, serine racemase knockout (SRKO) mice, and their wild-type littermates. SRKO mice displayed impairments in investigation-elicited gamma power that corresponded with reduced short-term social recognition and enhanced background (pre-investigation) gamma activity. Additionally, SRKO mice exhibited sensory gating impairments in both evoked-gamma power and event-related potential amplitude. However, other biomarkers including the auditory steady-state response, sleep spindles, and state-specific power spectral density were generally neurotypical. In conclusion, SRKO mice demonstrate how chronic NMDAR hypofunction contributes to deficits in certain translationally-relevant EEG biomarkers altered in schizophrenia. Importantly, our gamma band findings suggest an aberrant signal-to-noise ratio impairing cognition that occurs with NMDAR hypofunction, potentially tied to impaired task-dependent alteration in functional connectivity.
format article
author David D. Aguilar
Leana K. Radzik
Felipe L. Schiffino
Oluwarotimi O. Folorunso
Mark R. Zielinski
Joseph T. Coyle
Darrick T. Balu
James M. McNally
author_facet David D. Aguilar
Leana K. Radzik
Felipe L. Schiffino
Oluwarotimi O. Folorunso
Mark R. Zielinski
Joseph T. Coyle
Darrick T. Balu
James M. McNally
author_sort David D. Aguilar
title Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
title_short Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
title_full Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
title_fullStr Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
title_full_unstemmed Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
title_sort altered neural oscillations and behavior in a genetic mouse model of nmda receptor hypofunction
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/f8ea1784276d4c4a8fbcc40d7b2e1e8c
work_keys_str_mv AT daviddaguilar alteredneuraloscillationsandbehaviorinageneticmousemodelofnmdareceptorhypofunction
AT leanakradzik alteredneuraloscillationsandbehaviorinageneticmousemodelofnmdareceptorhypofunction
AT felipelschiffino alteredneuraloscillationsandbehaviorinageneticmousemodelofnmdareceptorhypofunction
AT oluwarotimiofolorunso alteredneuraloscillationsandbehaviorinageneticmousemodelofnmdareceptorhypofunction
AT markrzielinski alteredneuraloscillationsandbehaviorinageneticmousemodelofnmdareceptorhypofunction
AT josephtcoyle alteredneuraloscillationsandbehaviorinageneticmousemodelofnmdareceptorhypofunction
AT darricktbalu alteredneuraloscillationsandbehaviorinageneticmousemodelofnmdareceptorhypofunction
AT jamesmmcnally alteredneuraloscillationsandbehaviorinageneticmousemodelofnmdareceptorhypofunction
_version_ 1718392591315107840